Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/21/1995 | US5468487 Extracted substance having anti-HIV activity |
11/21/1995 | US5468472 Topical process for lightening the skin or treating pigmental blemishes using a composition containing 4-thioresorcin derivatives |
11/21/1995 | US5468469 Methods of using azo dyes and their derivatives |
11/21/1995 | CA2149854A1 Substituted furoxanes |
11/21/1995 | CA2149501A1 Glucopyranoside benzothiophenes |
11/21/1995 | CA2033480C Indolyl-3 polyamines useful as antagonists of excitatory amino acid neurotransmitters |
11/21/1995 | CA1337604C Phospholipid complexes of extract of vitis vinifera, their preparation process and pharmaceutical and cosmetic compositions containing them |
11/21/1995 | CA1337603C Dibenz[b,e]oxepin derivative and antiallergic and antiinflammatory agent |
11/21/1995 | CA1337600C Quinolone antibacterial compounds |
11/21/1995 | CA1337591C Therapeutic composition comprising oestrogen and antioestrogen |
11/21/1995 | CA1337590C Reduction of anthracycline-induced cardiotoxicity |
11/20/1995 | EP0690712A4 Taxanes having a pyridyl substituted side-chain |
11/20/1995 | CA2149691A1 Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia |
11/19/1995 | CA2149608A1 Tetrahydrobenz¬cd|indazoles |
11/16/1995 | WO1995030901A1 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans |
11/16/1995 | WO1995030746A1 Antisense inhibition of hepatitis c virus |
11/16/1995 | WO1995030741A1 Receptor-deficient animals and cell lines derived therefrom, and uses thereof |
11/16/1995 | WO1995030683A1 Adenosine derivatives |
11/16/1995 | WO1995030675A1 Biphenylcarboxamides useful as 5-ht1d antagonists |
11/16/1995 | WO1995030674A1 Morpholine derivatives and their use as antagonists of tachikinins |
11/16/1995 | WO1995030673A1 Anti-cancer compounds containing cyclopentaquinazoline ring |
11/16/1995 | WO1995030670A2 Pyranone compounds useful to treat retroviral infections |
11/16/1995 | WO1995030664A1 New di-oxadiazole derivatives as antihyperglycemic agents |
11/16/1995 | WO1995030646A1 Compounds containing a michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions |
11/16/1995 | WO1995030645A1 Amide derivatives and their therapeutic use |
11/16/1995 | WO1995030644A1 Amide derivatives and their therapeutic use |
11/16/1995 | WO1995030642A1 Combinatorial dihydrobenzopyran library |
11/16/1995 | WO1995030641A1 Nitro compounds and their compositions having anti-inflammatory, analgesic and anti-thrombotic acitivities |
11/16/1995 | WO1995030640A1 Substituted fused and bridged bicyclic compounds as therapeutic agents |
11/16/1995 | WO1995030441A1 Composition containing a solubilized antibacterial agent |
11/16/1995 | WO1995030440A1 Keratin-storable antifungal composition for external use |
11/16/1995 | WO1995030433A1 A novel brain endothelial cell protein and methods for its use |
11/16/1995 | WO1995030425A1 Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions |
11/16/1995 | WO1995030424A1 O-desulfated heparin derivatives, methods of making and uses thereof |
11/16/1995 | WO1995030423A2 Cancer treatment and metastasis prevention |
11/16/1995 | WO1995030422A1 Controlled-release dosage forms of azithromycin |
11/16/1995 | WO1995030421A1 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration |
11/16/1995 | WO1995030420A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
11/16/1995 | WO1995030419A1 Suppression, by 5-lipoxygenase inhibitors, of bone resorption |
11/16/1995 | WO1995030417A1 Potentiated antibiotic composition |
11/16/1995 | WO1995030416A1 The use of famotidine and related compounds in the treatment of movement disorders |
11/16/1995 | WO1995030415A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
11/16/1995 | WO1995030414A1 An improved ocular care solution |
11/16/1995 | WO1995030413A1 Hematopoietic stem cell proliferation accelerator |
11/16/1995 | WO1995030412A1 Cytokine potentiator and remedy for diseases wherein cytokine activity is reduced |
11/16/1995 | WO1995028934A3 Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers |
11/16/1995 | WO1995024497A3 Enzymatic preparation of polysaccharides |
11/16/1995 | DE4417038A1 New retinyl lipoate esters |
11/16/1995 | DE4416769A1 Effervescent medicament comprising isosorbide-5-mono:nitrate |
11/16/1995 | DE4416674A1 Topische Zubereitung enthaltend Aciclovir The topical preparation containing acyclovir |
11/16/1995 | DE19516631A1 Ungesättigte Taxan-Verbindungen Unsaturated taxane compounds |
11/16/1995 | CA2190027A1 A novel brain endothelial cell protein and methods for its use |
11/16/1995 | CA2190017A1 New di-oxadiazole derivatives as antihyperglycemic agents |
11/16/1995 | CA2190009A1 Amide derivatives and their therapeutic use |
11/16/1995 | CA2189634A1 Combinatorial dihydrobenzopyran library |
11/16/1995 | CA2189337A1 Compounds containing a michael-acceptor, especially maleimide or maleic acid derivatives, directly or indirectly linked to a chromophore and their use in long lasting sunscreen compositions |
11/16/1995 | CA2189336A1 Treatment for atherosclerosis and other cardiovascular and inflammatory diseases |
11/16/1995 | CA2189141A1 Morpholine derivatives and their use as antagonists of tachikinins |
11/16/1995 | CA2189125A1 Method of fluorescent detection of nucleic acids and cytoskeleton elements using bis-dicationic aryl furans |
11/16/1995 | CA2189038A1 O-desulfated heparin derivatives, methods of making and uses thereof |
11/16/1995 | CA2186847A1 Adenosine derivatives |
11/16/1995 | CA2166722A1 Use of vitamin e tocopheryl derivatives in ophthalmic compositions |
11/15/1995 | EP0682030A1 8-Amino-10(azabicycloalkyl)-pyrido[1,2,3-d,e] [1,3,4] benzoxadiazine derivatives, process for their preparation and antibacterial agents containing them |
11/15/1995 | EP0682028A1 5,6-Dihydro-4H-thieno 3,4-C pyrroleerivatives, their preparation and their therapeutic use |
11/15/1995 | EP0682027A1 Pyrrolopyrimidine derivatives with antiproliferative action |
11/15/1995 | EP0682026A1 "Stable crystalline (6S)- and (6R)-tetrahydrofolic acid" |
11/15/1995 | EP0682025A1 5,6-dihydro-4H-imidazo 2',1':2,3 imidazo 4,5,1-ij quinoline and 4,5-dihydroimidazo 1,2-a pyrrolo 1,2,3-cd benzimidazol derivatives |
11/15/1995 | EP0682024A1 Cyclohexane derivatives, processes for their preparation and their use as glucose-6-phosphatase inhibitors |
11/15/1995 | EP0682021A1 Benzimidazoles, medicines containing them and process for their preparation |
11/15/1995 | EP0682020A1 Fumagillol derivatives useful as angiogenesis inhibitors |
11/15/1995 | EP0682017A1 Substituted bicycle heteroaroylguanidines, their preparation and their application in medicaments and diagnostic agents |
11/15/1995 | EP0682016A1 Pyridine derivatives |
11/15/1995 | EP0682015A1 Piperidine derivates and anti-platelet agents containing the same |
11/15/1995 | EP0682011A1 New derivatives of serine, their preparation and their use in cosmetic and dermatologic compositions |
11/15/1995 | EP0682009A2 Intermediate compounds for preparing endothelin-receptor antagonist triterpene derivatives |
11/15/1995 | EP0681842A2 Ligand-mediated immunofunctional hormone binding protein assay method |
11/15/1995 | EP0681840A1 Use of phosphate diester for the treatment of retinal diseases |
11/15/1995 | EP0681839A2 A pharmaceutical preparation comprising an acylcarnitine |
11/15/1995 | EP0681838A1 Analgesic medicinal composition |
11/15/1995 | EP0681837A1 Method for lowering serum cholesterol with 1,1,2-triphenylbut-1-ene derivatives |
11/15/1995 | EP0681836A1 Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives |
11/15/1995 | EP0681835A1 Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives |
11/15/1995 | EP0681831A2 Use of extracts of filamentous bacteria as cosmetic agents against skin aging |
11/15/1995 | EP0681788A2 Dioxabicyclo[3.3.0] octane derivatives, e.g. sesamin etc., for prevention or alleviation of allergy symptoms |
11/15/1995 | EP0681590A1 Anticoagulant composition |
11/15/1995 | EP0681587A1 Side chain fluoro substituted 3-carboxysteroids |
11/15/1995 | EP0681586A1 Oligodeoxynucleotides containing 5-alkyl-, 5-(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds |
11/15/1995 | EP0681584A1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
11/15/1995 | EP0681582A1 Pyrazole derivatives and pharmaceutical compositions thereof |
11/15/1995 | EP0681576A1 Oxime derivatives |
11/15/1995 | EP0681575A1 Process for the preparation of baccatin iii analogs bearing new c2 and c4 functional groups |
11/15/1995 | EP0681574A1 C7 taxane derivatives and pharmaceutical compositions containing them |
11/15/1995 | EP0681573A1 C2 taxane derivatives and pharmaceutical compositions containing them |
11/15/1995 | EP0681571A1 Spiro-substituted azacycles as tachykinin receptor antagonists |
11/15/1995 | EP0681569A1 Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
11/15/1995 | EP0681483A1 Compositions and methods for delivery of genetic material |
11/15/1995 | EP0681482A1 Localization of therapeutic agents |
11/15/1995 | EP0681477A1 Genetic modification of neural stem cells |
11/15/1995 | EP0681476A1 Unit dose form of bismuth subsalicylate. |
11/15/1995 | EP0681475A1 Therapeutic inhibitors of vascular smooth muscle cells |